CHA News Article

FDA Warns Against Using Wallcur IV Solutions

The Food and Drug Administration (FDA) has alerted health care professionals not to use Wallcur, LLC, simulated intravenous products in human or animal patients. The products, which may state “for clinical simulation,” are for training purposes only, but in some instances have been administered to patients and resulted in serious adverse events. FDA reminds providers that before administering IV solutions to patients, they should carefully check the labels.